Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF-Reference-Cited by-同舟云学术

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF

Published:2014-07 Issue:7 Volume:25 Page:1442-1447
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chauffert B.,Feuvret L.,Bonnetain F.,Taillandier L.,Frappaz D.,Taillia H.,Schott R.,Honnorat J.,Fabbro M.,Tennevet I.,Ghiringhelli F.,Guillamo J.S.,Durando X.,Castera D.,Frenay M.,Campello C.,Dalban C.,Skrzypski J.,Chinot O.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/7/1442/19446596/mdu148.pdf

Reference13 articles.

1. Randomized multicenter phase II trial of irinotecan and bevacizumab as neoadjuvant and adjuvant to temozolomide-based chemoradiation versus chemoradiation for unresectable glioblastoma: Definitive results of the TEMAVIR ANOCEF study (LBA; ESMO 2012);Chauffert;Ann Oncol,2012

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial;Mirimanoff;J Clin Oncol,2006

4. Bevacizumab plus irinotecan in recurrent glioblastoma multiform;Vredenburgh;J Clin Oncol,2007

5. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma;Bleehen;Br J Cancer,1991

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse;Advanced Materials;2024-08-29

2. Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis;Neurosurgical Review;2024-08-20

3. Bevacizumab for Glioblastoma Multiforme: A Literature Review;JAP Academy Journal;2024-06-01

4. Modelling and simulation of anisotropic growth in brain tumours through poroelasticity: A study of ventricular compression and therapeutic protocols;Computational Mechanics;2024-04-25

5. A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy;Discover Oncology;2024-03-22